Symposium EN-01 (UG)
Nov. 16 (Fri)
08:30-10:00
Minimal invasive therapy of early gastric cancer: from ESD to surgery 101 (1F)
Chairperson(s) Hyung-Ho Kim (Seongnam), Takuji Gotoda (Tokyo)
08:30-08:50 How to choose a patient with early gastric cancer who can be treated with endoscopic submucosal dissection Ning Bo/ Enqiang Linghu
(Beijing)
08:50-09:10 ESD for early gastric cancer with undifferentiated histology: do we have enough data? Takuji Gotoda
(Tokyo)
09:10-09:30 Risk stratification of noncurative ESD: do all patient need additional treatment? Jun Chul Park
(Seoul)
09:30-09:50 Sentinel node navigation surgery for early gastric cancer: when and how to perform? Masanori Terashima
(Nagaizumi)
09:50-10:00 Q&As
Symposium EN-02 (LG)
Nov. 16 (Fri)
08:30-10:00
Progress in the detection and management of colorectal neoplasm 102 (1F)
Chairperson(s) Hermann Brenner (Heidelberg), Han-Mo Chiu (Taipei)
08:30-08:50 Image enhanced endoscopy in colorectal cancer screening: current status Wai Keung Leung
(Hong Kong)
08:50-09:10 Computer-aided detection and histopathology prediction for colorectal polyps Jeong-Sik Byeon
(Seoul)
09:10-09:30 Detection and removal of serrated lesions Hyo-Joon Yang
(Seoul)
09:30-09:50 Recent advances in colorectal ESD Takahisa Matsuda
(Tokyo)
09:50-10:00 Q&As
Symposium LV-01
Nov. 16 (Fri)
08:30-10:00
Chronic hepatitis B: current medication 103 (1F)
Chairperson(s) Seung Kew Yoon (Seoul), George Lau (Hong Kong)
08:30-08:50 Can we stop the neucleot(s)ide analogue? George Lau
(Hong Kong)
08:50-09:10 Prevention of new HBV infection: nucleotide analogue in pregnant women and vaccination Henry LY Chan
(Hong Kong)
09:10-09:30 HBV and HCV coinfection Jidong Jia
(Beijing)
09:30-09:50 Bepatitis B prophylaxis and occult hepatitis B in immunocompromized patients: to whom and how long Seng Gee Lim
(Singapore)
09:50-10:00 Q&As
Symposium PB-01
Nov. 16 (Fri)
08:30-10:00
New insights in the biliary system 104 (1F)
Chairperson(s) D. Nageshwar Reddy (Hyderabad), Ho Soon Choi (Seoul), Shutian Zhang (Beijing)
08:30-08:50 Optimal evaluation of premalignant biliary lesions Seon Mee Park
(Cheongju)
08:50-09:10 Optimal approach to the indeterminate bile duct stricture Hsiu-Po Wang
(Taipei)
09:10-09:30 Updates on difficult biliary stones management Chang-Il Kwon
(Seongnam)
09:30-09:50 Best Endoscopic drainage of biliary system Shutian Zhang
(Beijing)
09:50-10:00 Q&As
Symposium GI-01 (Motility)
Nov. 16 (Fri)
08:30-10:00
Updates in gastrointestinal neurogastro-motility disorders 105 (1F)
Chairperson(s) Nicholas J Talley (Newcastle), Kwang Jae Lee (Suwon)
08:30-08:50 Approach to esophageal disorders John Pandolfino
(Wilmette)
08:50-09:10 Approach to gastric disorders Nicholas J Talley
(Newcastle)
09:10-09:30 Approach to bowel disorders Eamonn Quigley
(Houston)
09:30-09:50 Differences of guidelines between Asia and West Jung-Ho Park
(Seoul)
09:50-10:00 Q&As
SIDDS 1
Nov. 16 (Fri)
08:30-10:00
Understanding of molecular alteration: the cornerstone for treatment of GI cancer 202 (2F)
Chairperson(s) James R. Goldenring (Nashville), Seung Woo Park (Seoul)
08:30-08:55 The mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis James R. Goldenring
(Nashville)
08:55-09:20 Proteomic Multi-Marker Panel for Early Detection of GI cancers Using Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS) Youngsoo Kim
(Seoul)
09:20-09:45 Control of GI cancer using CRIPR-Cas9 Hyongbum Kim
(Seoul)
09:40-10:00 Q&As
Symposium EN-03 (UG)
Nov. 16 (Fri)
08:30-10:00
Recent update in treatment for GI subepithelial tumors 203 (2F)
Chairperson(s) Hoon Jai Chun (Seoul), Seigo Kitano (Oita)
08:30-08:50 Resection for subepithelial tumors: when is it needed? Jie-Hyun Kim
(Seoul)
08:50-09:10 Endoscopic resection of subepithelial tumors via standard EMR/ESD technique Kyoung Oh Kim
(Inchoen)
09:10-09:30 Endoscopic full thickness resection of subepithelial tumors Chan Gyoo Kim
(Goyang)
09:30-09:50 Minimally invasive surgery for subepithelial tumors Osamu Goto
(Tokyo)
09:50-10:00 Q&As
E-poster Presentation-01 (UG, Motility)
Nov. 16 (Fri)
08:30-10:00
Esophagus R1A (3F)
Chairperson(s) Jung-Ho Park (Seoul), William Tam (Adelaide)
08:30-08:36 Utility of adjunctive rapid drink test (RDT) during high resolution esophageal manometry (HREM) in sitting position for evaluating functional esophagogastric junction outflow obstruction (EGJOO) Tanisa Patcharatrakul
(Bangkok)
08:36-08:42 Reduction of proton pump inhibitor (PPI) usage in patients with gastroesophageal reflux disease (GERD) after undergoing stretta procedure, an east malaysia perspective. Phei Oon Tan
(Kota Kinabalu)
08:42-08:48 The relationship between hypomotility disorders, hypotensive lower esophageal sphincter and gastroesophageal reflux diseases symptoms. Hang Dao
(Hanoi)
08:48-08:54 Taking the next steps in endoscopic visual assessment of barretts esophagus Roxana Chis
(Kingston)
08:54-09:00 Do we need to exclude epigastric symptoms for GERD diagnosis? Mengyu Zhang
(Guangzhou)
09:00-09:06 Effect of anti-reflux mucosectomy (ARMS) for refractory GERD underwent 24-hour pH-impedance (MII-pH) off PPI before and after ARMS Kazuya Sumi
(Tokyo)
09:06-09:12 Immunohistochemical expression of transient receptor vanilloid 4 (TRPV4), a marker of visceral hypersensitivity in NERD and controls Mung Seong Wong
(Kota Bharu)
09:12-09:18 Normative values for 24-hours ambulatory multichannel intraluminal impedance and pH monitoring (sandhill and MMS systems) in the malay population Su Fui Thung
(Kota Bharu)
09:18-09:24 Normative Chicago 3.0 metrics for high-resolution esophageal manometry (sandhill and MMS systems) in the malay population and the effects of boluses types and postures on normative Metrics Su Fui Thung
(Kota Bharu)
09:24-09:30 Effects of provocative bolus and positions on chicago 3.0 metrics in normal malay population. Su Fui Thung
(Kota Bharu)
09:30-09:36 Clinical characteristics of untreated achalasia patients in Taiwan: a prospective study based on high-resolution impedance manometry Ping-Huei Tseng
(Taipei)
09:36-09:42 Prevalence and risk factors of Barrett's esophagus in Vietnamese patients with upper gastrointestinal symptoms Quyen Thi Trieu Pham
(Ho Chi Minh)
09:42-09:48 The endoscopic and clinicopathological characteristics of Barrett's esophagus in Vietnamese patients Truc Le Thanh Tran
(Ho Chi Minh)
09:48-09:54 Pneumatic dilation, more than a treatment of achalasia - evaluation of compliance of esophagogastric junction by pneumatic dilation balloon before POEM Hailong Cao
(Tianjin)
E-poster Presentations-02 (LG)
Nov. 16 (Fri)
08:30-10:00
Inflammatory bowel disease (1) R1C (3F)
Chairperson(s) Tae Oh Kim (Busan), Chang Hwan Choi (Seoul)
08:30-08:36 Do patients, their families, and doctors really think the same? A population-based, multi-centered cohort study using the inflammatory bowel disease disability index Jun Shen
(Shanghai)
08:36-08:42 Using magnetic resonance imaging to evaluate the effectiveness in perianal fistulising Crohns disease Jun Shen
(Shanghai)
08:42-08:48 Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease Sang Hyoung Park
(Seoul)
08:48-08:54 Endoscopic diagnosis of non-pedunculated dysplasia during surveillance in the ulcerative colitis: a survey-based, multinational studies Dong-Hoon Yang
(Seoul)
08:54-09:00 Infliximab trough levels are associated with transmural healing during maintenance treatment in pediatric Crohn's disease patients Ben Kang
(Daegu)
09:00-09:06 Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up Shin Ju Oh
(Seoul)
09:06-09:12 Histone H3 acetylation protects ulcerative colitis by inhibiting NF-B/p65 and enhancing intestinal epithelial barrier function Chunxiao Li
(Hangzhou)
09:12-09:18 Helicobacter pylori infection in inflammatory bowel disease: protective or harmful? Yang Yu
(Beijing)
09:18-09:24 The Efficacy and safety of adalimumab for the patients with moderate to severely active ulcerative colitis and predictors of response in Korea (EUREKA): preliminary results Chang Hwan Choi
(Seoul)
09:24-09:30 Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring Sung-Shuo Kao
(Kaohsiung)
09:30-09:36 Doctors perspectives on the use of traditional, complementary and alternative medicine in inflammatory bowel disease: the first doctors report in Asia Jessica Y L Ching
(Hong Kong)
E-poster Presentations-03 (LV)
Nov. 16 (Fri)
08:30-10:00
Acute hepatitis, viral hepatitis, liver failure, HCC R2A (3F)
Chairperson(s) Jong Young Choi (Seoul), Young Oh Kwon (Daegu)
08:30-08:36 Hormonal component of the pathogenesis of chronic liver disease Saidrakhim Nodirovich Lukmonov
(Tashkent)
08:36-08:42 Inflammatory cytokines and the change of Th1/Th2 balance as prognostic indicators for HCC in patients treated with transarterial chemoembolization Hae Lim Lee
(Bucheon)
08:42-08:48 Clinical characteristics of long term survivors following sorafenib treatment for unresectable hepatocellular carcinoma: Korean national multi-center retrospective cohort study Young Youn Cho
(Seoul)
08:48-08:54 Assessing HCV distribution among hard to reach populations in London using whole genome sequencing: report from the TB reach study Dewi Nur Aisyah
(Depok)
08:54-09:00 Modelling hepatitis C direct acting antiviral (DAA) treatment scale up among people who inject drugs in London: working towards WHO incidence elimination target by 2030 Dewi Nur Aisyah
(Depok)
09:00-09:06 Evaluation of utility of predictive models for acute-on-chronic liver failure Li Peng Margaret Teng
(Singapore)
09:06-09:12 Early hepatitis is the strongest risk factor for the development of severe dengue infection: a points-based risk-score to predict critical disease in dengue fever Madunil Anuk Niriella
(Ragama)
09:12-09:18 Barriers to hepatocellular carcinoma (HCC) surveillance in at-risk individuals in Thailand Palada Pitakkitnukun
(Bangkok)
09:18-09:24 Temporal profile of HEV RNA concentration in blood and stool in patients with acute hepatitis E Vijay Kumar Halkurike Jayadevappa
(Lucknow)
09:24-09:30 miRNA-221-5p promotes epithelial-mesenchymal transition in hepatocellular carcinoma through regulation of CD44/TGF-beta1 Na Ri Park
(Seoul)
09:30-09:36 Understanding recurrence related oncogenic kinases and metabolites in liver cancer Hongping Xia
(Singapore)
E-poster Presentations-04 (LG)
Nov. 16 (Fri)
08:30-10:00
Irritable bowel disease (IBS), microbiology R2C (3F)
Chairperson(s) Byung Ik Jang (Daegu), Shengtao Zhu (Beijing)
08:30-08:36 Maternal western-style diet alters gut microbiota of offspring and exacerbates intestinal inflammation in adulthood Hailong Cao
(Tianjin)
08:36-08:42 Profiles of bacteria-derived extracellular vesicles in stool, serum and urine in patients with colorectal cancer: a preliminary study Jae Ho Cho
(Seongnam)
08:42-08:48 Characteristics of mucosa-associated fungal microbiota during treatment in Crohn's disease Cong He
(Nanchang)
08:48-08:54 The impact of helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, prospective clinical trial Luyi Chen
(Hangzhou)
08:54-09:00 Bloating and its association with functional gastrointestinal disorders according to ROME III diagnostic criteria Kewin Tien Ho Siah
(Singapore)
09:00-09:06 Transcriptome and methylome profiling in a rat model of irritable bowel syndrome induced by stress Shengtao Zhu
(Beijing)
09:06-09:12 Investigating the functional role of clostridium hathewayi in colorectal carcinogenesis Thomas Kwong
(Hong Kong)
09:12-09:18 The impact of veterinary antibiotic residue in foods on obesity and antibiotic resistance through modulation of gut microbiota Wei-Kai Wu
(Taipei)
09:18-09:24 Overlapping functional GI disorders (FGID) and new-onset constipation associated with more GI symptom severity in FGID patients during hospitalization Tanisa Patcharatrakul
(Bangkok)
PG Course-LV (Korean)
Nov. 16 (Fri)
08:30-10:00
Concerning points and management during treatment for liver disease E1+2 (3F)
Chairperson(s) So Young Kwon (Seoul), June Sung Lee (Goyang)
08:30-08:50 During antiviral therapy for HBV Hyun Phil Shin
(Seoul)
08:50-09:10 During antiviral therapy for HCV In Hee Kim
(Jeonju)
09:10-09:30 During imunosuppressive therapy for Autoimmune liver disease Eun Ju Cho
(Seoul)
09:30-09:50 During systemic therapy for HCC Sung-Bum Cho
(Gwangju)
09:50-10:00 Q&As
Free Paper (PB 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (PB 01) E3 (3F)
Chairperson(s) Young Woo Choi (Daejeon), Kyu Taek Lee (Seoul)
08:30-08:40 Comparison of therapeutic efficacy and safety between standard-dose FOLFIRINOX and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer: a retrospective study Huapyong Kang
(Seoul)
08:40-08:50 Korean experiences with liposomal irinotecan for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy. Juyeon Oh
(Goyang)
08:50-09:00 Comparison of FOLFIRINOX and Gemcitabine with Nab-paclitaxel in Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer Registry (K-PAC) Jong-Chan Lee
(Seongnam)
09:00-09:10 Surveillance versus surgery for incidental, asymptomatic, small solid pseudopapillary neoplasm (SPN) of the pancreas Joune Seup Lee
(Seoul)
09:10-09:20 Efficacy of endobiliary radiofrequency ablation for malignant distal biliary obstruction: A propensity score matched multicenter study Eui Joo Kim
(Incheon)
Chairperson(s) Seokho Dong (Seoul), Don Haeng Lee (Incheon)
09:20-09:30 The importance of elevated serum viscosity in pancreaticobiliary cancer patients Hwang Seonyeong
(Seoul)
09:30-09:40 Prognostic impact of minimal Pelvic Fluid in pancreatic cancer stage III Young-Hwa Kim
(Incheon)
09:40-09:50 Chromogranin A as a prognostic marker in pancreatic adenocarcinoma Jung Hyun Jo
(Seoul)
09:50-10:00 complementary role of Serum DUPAN-2 for screening of Carbohydrate Antigen 19-9 in patients with pancreatico-biliary malignancy Jae Woo Kim
(Wonju)
Free Paper (GI Cancer 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (GI Cancer 01) E4 (3F)
Chairperson(s) Jin Tae Jung (Daegu), Su Youn Nam (Daegu)
08:30-08:40 Effects of a 12 week home-based exercise program in patients with high risk of gastric cancer: A pilot study Jeung Eun Lee
(Seoul)
08:40-08:50 Subepithelial spread of early gastric signet ring cell carcinoma: How far they can reach? Sun Hyung Kang
(Daejeon)
08:50-09:00 Gastric cancer with lymph node metastasis more than 15 (N3b): is it really stage III disease? Sa-Hong Kim
(Seoul)
09:00-09:10 Predictive factors of lymph node metastasis in early gastric cancer patients with Seiwert type II/III Min Young Son
(Busan)
09:10-09:20 Abdominal computed tomography compared with endoscopic ultrasound sonography for the diagnosis of gastric subepithelial tumors Cheal Wung Huh
(Incheon)
Chairperson(s) Eun Kwang Choi (Jeju), Seung-Ok Lee (Jeonju)
09:30-09:40 Incidence and prognosis of subsequent cholangiocarcinoma in patients with hepatic resection for bile duct stones Seon Mee Park
(Cheongju)
09:40-09:50 Validation of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system for pancreatic adenocarcinoma: Using Korean pancreatic cancer (K-PAC) registry Dong Woo Shin
(Seongnam)
09:50-10:00 Clinicopathologic characteristics of Intraductal Papillary Neoplasm of Bile duct (IPNB) after central review: Korean multi-center collaboration study Jae Ri Kim
(Seoul)
10:00-10:10 Adjuvant gemcitabine-based chemotherapy vs concurrent chemoradiotherapy after R0 resection for pancreatic ductal adenocarcinoma: A propensity score-matched analysis Min Su You
(Seoul)
Free Paper (LG 1) (Korean)
Nov. 16 (Fri)
08:30-10:00
KDDW Free Paper (LG 01) E5 (3F)
Chairperson(s) Kyu Chan Huh (Daejeon), Sung-Ae Jung (Seoul)
08:30-08:40 A trial for the administration of a functionally enhanced tonsil-derived mesenchymal stem cells in a chronic colitis model. Yang Hee Joo
(Seoul)
08:40-08:50 The ability of epithelial regeneration is reduced in the Crohn's disease patient-derived organoids, especially in TNF-alpha enriched condition. Sung Noh Hong
(Seoul)
08:50-09:00 Diagnostic role of NOD signaling and apoptosis tests in patients with XIAP-deficient IBD Seak Hee Oh
(Seoul)
09:00-09:10 Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers Soo-Kyung Park
(Seoul)
09:10-09:20 Identification of prominent hub genes of colorectal cancer : Using network analysis of gene expression data Seong Ji Choi
(Seoul)
Chairperson(s) Byong Duk Ye (Seoul), Geom Seog Seo (Iksan)
09:20-09:30 Vegetarianism as a protective factor for asymptomatic colonic diverticulosis; A cross-sectional, case-control study between Buddhist priests and general population Jihun Bong
(Goyang)
09:30-09:40 Clinical outcome after endoscopic decompression of sigmoid volvulus; A multicenter-retrospective study, Daejeon-Chungchung intestinal research group Hee Seok Moon
(Daejeon)
09:40-09:50 Identification and validation of a peptide probe binding specifically to colon cancer cells Younghee Choe
(Seoul)
Mastering NBI
Nov. 16 (Fri)
08:50-11:40
Mastering NBI - Collaboration with ANBIIG 205 (2F)
Chairperson(s) Rajvinder Singh (Adelaide), Bo-In Lee (Seoul)
08:50 - 09:10 NBI in the Oesophagus: Current and best practice, 2018 Rajvinder Singh
(Adelaide)
09:10 - 09:25 Case discussion: esophagus Jung-Wook Kim
(Seoul)
09:25 - 09:45 NBI detection and characterization of stomach cancers Mitsuhiro Fujishiro
(Tokyo)
09:45 - 10:00 Case discussion: stomach Jun-Hyung Cho
(Seoul)
10:30 - 10:50 NBI detection and characterization of colorectal polyps Nozomu Kobayashi
(Tochigi)
10:50 - 11:05 Case discussion: colon, histologic prediction Han Hee Lee
(Seoul)
11:05 - 11:25 Estimation of invasion depth in colorectal lesions David Hewett
(Brisbane)
11:25 - 11:40 Case discussion: estimation of invasion depth Yunho Jung
(Cheonan)
Free Paper (LG 2) (Korean & English)
Nov. 16 (Fri)
10:20-11:10
KDDW Free Paper (LG 02) E5 (3F)
Chairperson(s) Jin-Oh Kim (Seoul), Chang Hwan Choi (Seoul)
10:20-10:30 Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin Kyung Mo Yoo
(Seoul)
10:30-10:40 Clinicopathological features of malignant tumors of small bowel diagnosed by video capsule endoscopy and balloon-assisted enteroscopy: A single center experience Sunghee Kam
(Seoul)
10:40-10:50 Modifiable lifestyle risk factors and the risk of colorectal neoplasia recurrence Kyungjin Ko
(Seoul)
10:50-11:00 Differences in the clinicopathologic characteristics between right- and left-sided colon cancer Hannah Ra
(Incheon)
11:00-11:10 Epidemiology of colorectal cancer in Northern Malaysia: A 7-year review (2008-2014) Mohamad Fadli Abd Rahman
(Alor Setar)
SIDDS 2
Nov. 16 (Fri)
10:30-12:00
Host-microbiome interactions in Gut and Liver disease 202 (2F)
Chairperson(s) Takanori Kanai (Tokyo), Jin-Wook Kim (Seongnam)
10:30-10:50 Understanding human gut microbiome and diseases Jongsik Chun
(Seoul)
10:50-11:10 The innate immune capacity of macrophages in regulation of intestinal barrier function and inflammation Eunok Im
(Busan)
11:10-11:30 T cells and immunoregulatory cytokines in intestinal inflammation: implication on IBD treatment Takanori Kanai
(Tokyo)
11:30-11:50 Gut-liver axis in Liver diseases Ki Tae Suk
(Chuncheon)
11:50-12:00 Q&As
Plenary 2 (UG, LG, Motility)
Nov. 16 (Fri)
10:30-12:00
KDDW Plenary 2 (UG, LG, Motility) 203 (2F)
Chairperson(s) Yong Chan Lee (Seoul), Tae Il Kim (Seoul), In Kyung Sung (Seoul)
10:30-10:45 Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on infliximab maintenance therapy Eun Hye Oh
(Seoul)
10:45-11:00 Link between symptom severity, gender and self-reported psychiatric disorders in patients with organic and functional gastrointestinal disorders: A prospective cohort study in 12,806 consecutive patients referred for specialist treatment at a tertiary cen Ayesha Shah
(Brisbane)
11:00-11:15 utility of measurement EGJ distensibility in patients with achalasia Junsu Chang
(Sungnam)
11:15-11:30 Transient Receptor Vanilloid 4 (TRPV4), a Marker of Visceral Hypersensitivity is present in NERD and Controls Nazihah Azis
(Kota Bharu)
11:30-11:45 Metachronous recurrence of gastric epithelial neoplasia according to Helicobacter pylori infection and microsatellite state : Long term follow-up results and clinical outcome Jaeyoung Kim
(Suwon)
11:45-12:00 Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged <50 years Hyun Beom Chae
(Seoul)
PG Course-Endoscopy (Korean)
Nov. 16 (Fri)
10:30-12:00
Basic drainage technique of Pancreatobiliary diseases (PG course) E1+2 (3F)
Chairperson(s) Sang-Heum Park (Cheonan), Dae Hwan Kang (Yangsan)
10:30-10:50 Biliary drainage: benign and malignant distal biliary obstruction Dong-Won Ahn
(Seoul)
10:50-11:10 Biliary drainage: advanced hilar obstruction Tae Hoon Lee
(Cheonan)
11:10-11:30 Obstructed pancreatic duct drainage: transpapillary and EUS-guided drainage Se Woo Park
(Hwaseong)
11:30-11:50 Gallbladder drainage: transpapillary and transmural drainage Woo Hyun Paik
(Seoul)
11:50-12:00 Q&As
Free Paper (PB 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (PB 02) E3 (3F)
Chairperson(s) Tae Nyeun Kim (Daegu), Young Deok Cho (Seoul)
10:30-10:40 Differences in clinical features and outcomes of hypertriglyceridemia induced acute pancreatitis from the prospective acute pancreatitis registry of 558 patients. So Jeong Kim
(Incheon)
10:40-10:50 Acute pancreatitis in pregnant women. Features of diagnosis and treatment tactics Nurmurod Ne'mat O'g'li Esanov
(Tashkent)
10:50-11:00 Risk factors and outcomes of deep vein thrombosis in patients with necrotizing pancreatitis Du-Jiang Yang
(Chengdu)
Chairperson(s) Hong Sik Lee (Seoul), Byung Moo Yoo (Suwon)
11:00-11:10 Comparison between groove pancreatitis and groove pancreatitis with extensive chronic pancreatitis Jae Hyuck Jun
(Daejeon)
11:10-11:20 Comparison of clinical outcomes between plastic stent and lumen-apposing metal stent for endoscopic ultrasound-guided drainage of peripancreatic fluid collections: A retrospective single centre experience Chang Min Cho
(Daegu)
11:20-11:30 Efficacy of intramuscular diclofenac in the prevention of post-ERCP pancreatitis: A prospective, randomized, placebo-controlled study Byung Sam Park
(Daegu)
Free Paper (GI Cancer 2) (Korean & English)
Nov. 16 (Fri)
10:30-12:00
KDDW Free Paper (GI Cancer 02) E4 (3F)
Chairperson(s) Yun Jeong Lim (Goyang), Bora Keum (Seoul)
10:30-10:40 Changing trends of colonoscopic burden: A nationwide population-based study in Korea Jae Myung Cha
(Seoul)
10:40-10:50 Risk of developing colorectal cancer based on the prior screening behaviors: Population-based cohort study. Su Young Kim
(Wonju)
10:50-11:00 Colorectal cancer screening among cancer survivors in the US Adeyinka O Laiyemo
(Washington)
11:00-11:10 Metabolically healthy obesity is associated with an increased risk of colorectal neoplasia recurrence Hyun Beom Chae
(Seoul)
11:10-11:20 Association between low relative muscle mass and the risk of colorectal neoplasia recurrence in Korean men and women Kyung Mo Yoo
(Seoul)
Chairperson(s) Jin-Hyeok Hwang (Seongnam), Jae Hee Cho (Incheon)
11:20-11:30 Neoadjuvant FOLFIRINOX in patients with locally advanced pancreatic cancer Young Hoon Choi
(Seoul)
11:30-11:40 Lymphocyte-to-monocyte ratio is a valuable marker for predicting survival in patients with gallbladder cancer undergoing chemotherapy compared to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio Young Hoon Choi
(Seoul)
11:40-11:50 Clinicopathologic characteristics and kras molecular alterations of adenosquamous carcinoma of the pancreas compared to pancreatic ductal adenocarcinoma Sun Mi Lee
(Jeju)
11:50-12:00 Detection of circulating tumor DNA and its application in pancreatic cancer patients Joo Kyung Park
(Seoul)
Okuda Lectureship
Nov. 16 (Fri)
11:00-11:30
Okuda Lectureship Auditorium (3F)
Chairperson(s) Rakesh Aggarwal (Lucknow), Yungsang Lee (Seoul)
11:00-11:30 Challenges of hepatitis B in the era of antiviral therapy Henry LY Chan
(Hong Kong)
Topic Forum (LG) (Korean)
Nov. 16 (Fri)
11:10-12:00
Topic Forum (LG) E5 (3F)
Chairperson(s) Hiun Suk Chae (Uijeongbu), Young-Eun Joo (Gwangju)
11:10-11:20 Risk factors including fecal markers for hospitalization in patients with ulcerative colitis Byung Jin Kwon
(Yangsan)
11:20-11:30 Mucosal healing is associated with transmural healing after 1-year treatment with anti-TNF agents in pediatric Crohn's disease patients Ben Kang
(Daegu)
11:30-11:40 Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy Eun Hye Oh
(Seoul)
11:40-12:00 Keynote Lecuture: Evolving monitoring for IBD patient care in clinical practice Byung Ik Jang
(Daegu)
Marshall & Warren Lectureship
Nov. 16 (Fri)
11:30-12:00
Marshall & Warren Lectureship Auditorium (3F)
Chairperson(s) Ian Roberts-Thomson (Hawthorn), Hyun Chae Jung (Seoul)
11:30-12:00 Chemoprevention of gastric cancer by H. pylori eradication and its underlying mechanism Nayoung Kim
(Seongnam)
Live Demonstration 1
Nov. 16 (Fri)
14:00-15:30
Live Demonstration 1 Auditorium (3F)
Chairperson(s) Chan Sup Shim (Seoul), Christopher Jen Lock Khor (Singapore), James Lau (Hong Kong)
Judge(s) Eun Taek Park (Busan), Rinaldi Lesmana (Jakarta), Akio Katanuma (Sapporo), Jin-Hyeok Hwang (Seongnam), TBA
14:00-15:30 LGI Hiroshi Kashida
14:00-15:30 PB Seungmin Bang
14:00-15:30 PB Se Woo Park
Symposium GI-02 (UG)
Nov. 16 (Fri)
14:00-15:30
Gastric carcinogenesis: Host, microbiome, and their interactions 101 (1F)
Chairperson(s) Kwong Ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20 Identification of genetic susceptibility for gastric cancer through genome-wide association studies Benjamin Wong
(Hong Kong)
14:20-14:40 Non-coding RNA and gastric cancer Sang Kil Lee
(Seoul)
14:40-15:00 Interactions between human and Helicobacter pylori in gastric carcinogenesis Richard Peek
(Nashville)
15:00-15:20 Non-Helicobacter pylori microbiome in gastric carcinogenesis Yoshio Yamaoka
(Yufu)
15:20-15:30 Q&As
Symposium EN-04 (UG)
Nov. 16 (Fri)
14:00-15:30
Recent advances of EUS: one more step 102 (1F)
Chairperson(s) Laurent Palazzo (Paris), Dong-Wan Seo (Seoul)
14:00-14:20 Enhanced EUS imaging: Elastography and contrast enhanced EUS Laurent Palazzo
(Paris)
14:20-14:40 EUS-FNA/FNB in the UGI tract: when and how? Rungsun Rerknimitr
(Bangkok)
14:40-15:00 Present status of EUS in pancreatic cystic lesions Yousuke Nakai
(Tokyo)
15:00-15:20 Interpretation of EUS-FNA/FNB specimen: Pathologist’s view Keetaek Jang
(Seoul)
15:20-15:30 Q&As
Symposium LV-02
Nov. 16 (Fri)
14:00-15:30
Chronic hepatitis B: future treatment for the cure 103 (1F)
Chairperson(s) Seung Woon Paik (Seoul), Shiv Kumar Sarin (New Delhi)
14:00-14:20 Potential therapeutic target in hepatitis B virus life cycle Jia-Horng Kao
(Taipei)
14:20-14:40 Current strategies to maximize HBsAg loss in patients with CHB Pietro Lampertico
(Milan)
14:40-15:00 Immunologic modulation for hepatitis B treatment Antonio Bertoletti
(Singapore)
15:00-15:20 Emerging drugs?& new therapeutic perspectives?for HBV Henry LY Chan
(Hong Kong)
15:20-15:30 Q&As
Symposium PB-02
Nov. 16 (Fri)
14:00-15:30
Cutting edge of pancreatic diseases 104 (1F)
Chairperson(s) Chengwei Tang (Chengdu), Hsiu-Po Wang (Taipei)
14:00-14:20 Updates on the management of severe acute pancreatitis Chengwei Tang
(Chengdu)
14:20-14:40 Pancreatic enzyme replacement therapy in chronic pancreatitis Hong Sik Lee
(Seoul)
14:40-15:00 Updates on Ig G4 related diseases Kazuichi Okazaki
(Hirakata)
15:00-15:20 Current status of pancreatic cystic neoplasm management Aiming Yang
(Beijing)
15:20-15:30 Q&As
Combined-01 (Liver, PB)
Nov. 16 (Fri)
14:00-15:30
Autoimmune diseases of the liver and biliary system: the essentials 105 (1F)
Chairperson(s) Myung-Hwan Kim (Seoul), Sook-Hyang Jeong (Seongnam)
14:00-14:20 Autoimmune hepatitis - 2018 Update Atsushi Tanaka
(Tokyo)
14:20-14:40 Primary biliary cholangitis: from diagnosis to treatment Kyung-Ah Kim
(Goyang)
14:40-15:00 Primary sclerosing cholangitis: what is the best management in the 21stcentury? Hiroyuki Isayama
(Tokyo)
15:00-15:20 IgG4-related sclerosing cholangitis: when to suspect, how to diagnose, and how to treat Taejun Song
(Seoul)
15:20-15:30 Q&As
Symposium GI-03 (LG)
Nov. 16 (Fri)
14:00-15:30
Shifting paradigm in IBD management 202 (2F)
Chairperson(s) Joo Sung Kim (Seoul), Siew Chien Ng (Hong Kong)
14:00-14:20 New drugs on the horizon: Targeting cytokines, cell trafficking, and more Choon Jin Ooi
(Singapore)
14:20-14:40 Fecal microbiota transplantation for IBD: Ready to use? Siew Chien Ng
(Hong Kong)
14:40-15:00 Toward improving quality of care in IBD management David Todd Rubin
(Chicago)
15:00-15:20 Things you should know when managing elderly IBD patients Jae Hee Cheon
(Seoul)
15:20-15:30 Q&As
Symposium EN-05 (UG)
Nov. 16 (Fri)
14:00-15:30
Current status and future direction for early esophageal cancer treatment strategy 203 (2F)
Chairperson(s) Joo Young Cho (Seongnam), Tsuneo Oyama (Saku)
14:00-14:20 High magnification and NBI imaging endoscopy for early esophageal cancer Gwang Ha Kim
(Busan)
14:20-14:40 ESD with multimodal treatment for esophageal cancer Tsuneo Oyama
(Saku)
14:40-15:00 Ablation therapy for esophageal cancer: when and how? Jeong Hoon Lee
(Seoul)
15:00-15:20 Management of esophageal stricture after endoscopic treatment Yang Won Min
(Seoul)
15:20-15:30 Q&As
APDW 2018 Plenary Oral 1
Nov. 16 (Fri)
14:00-15:30
Plenary Oral 1 205A (2F)
Chairperson(s) Jidong Jia (Beijing), Dong Ki Lee (Seoul)
14:00-14:10 EUS-guided gastrojejunostomy using a lumen apposing metal stent in patients with symptomatic gastric outlet obstruction Adeel Urrehman
(Karachi)
14:10-14:20 Higher peak dose rather than prolonged duration of corticosteroid increases the risk of hepatitis flare in patients with chronic hepatitis B Becky Wing-Yan Yuen
(Shatin)
14:20-14:30 Roux en Y gastric bypass is associated with better short term cardiovascular risk reduction than sleeve gastrectomy in a multi-ethnic cohort Baldwin Po Man Yeung
(Singapore)
14:30-14:40 Incidence and risk factors for alcohol relapse after liver transplantation for alcoholic liver disease. Dong Hyun Sinn
(Seoul)
14:40-14:50 New staining method using antibody of methionyl-tRNA synthetase for brushing cytology can differentiate indeterminate bile duct strictures. Sung Ill Jang
(Seoul)
14:50-15:00 Is the new T1 category defined by the 8th edition AJCC pancreatic cancer staging system an improvement? An evaluation by multinational data Wooil Kwon
(Seoul)
15:10-15:20 PCSK9 inhibits HCC cell malignant biological behavior via binding to GSTP1 Mingyan He
(Nanchang)
E-poster Presentations-05 (UG)
Nov. 16 (Fri)
14:00-15:30
H. pylori R1A (3F)
Chairperson(s) Jung Mogg Kim (Seoul), Khien Van Vu (Hanoi)
14:00-14:06 Prevalence of helicobacter pylori in eastern province Mongolia Munkhtur Dandar
(Choibalsan)
14:06-14:12 The role of migration inhibitory factor (MIF) in H. pylori infection and gastric cancer development Chun-Sheng Shen
(Kaohsiung)
14:12-14:18 Management of antibiotics-resistant helicobacter pylori infection -Perspectives from Vietnam Khien Van Vu
(Hanoi City)
14:18-14:24 Risk of overall mortality after helicobacter pylori treatment in patients with hypertension Young-Il Kim
(Goyang)
14:24-14:30 Efficacies of genotypic resistance-guided vs empirical therapy for refractory helicobacter pylori infection- A randomized controlled trial Jyh-Ming Liou
(Taipei)
14:30-14:36 Discriminating subjects with past helicobacter pylori infection among seronegative and unimpaired gastric secretory ability. Hyungyung Kwon
(Seoul)
14:36-14:42 Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria Ping-I Hsu
(Kaohsiung)
14:42-14:48 Modified amoxicillin triple therapy vs standard triple therapy for eradication of helicobacter pylori infection: A randomized control trial Dennis Franco Fernandez
(Manila)
14:48-14:54 The microbiota regulates bone marrow-derived mesenchymal stem cells in gastrointestinal cancer Huiying Shi
(Wuhan)
14:54-15:00 Association of helicobacter pylori infection with fatty liver infiltration in dyspeptic patients Basit Siddiqui
(Karachi)
15:00-15:06 Online registry for nationwide database of current trend of helicobacter pylori eradication in Korea: correlation of the density of antibiotics usage with eradication success Beom Jin Kim
(Seoul)
15:06-15:12 14-day bismuth high dose dual therapy is a robust second-line rescue therapy of H.pylori infection Alex Hwong-Ruey Leow
(Kuala Lumpur)
E-poster Presentations-06 (LG)
Nov. 16 (Fri)
14:00-15:30
Inflammatory bowel disease (2) R1C (3F)
Chairperson(s) Young Sook Park (Seoul), Zhihua Ran (Shanghai)
14:00-14:06 Efficacy of cumulative corticosteroid dose before the treatment with biologics on the outcome of UC patients: A retrospective multicenter experience Yoshitaka Ueno
(Hirosima)
14:06-14:12 Clinical significance of granulomas in Crohn`s disease: A meta-analysis Seung Wook Hong
(Seongnam)
14:12-14:18 Dose medical acceleration improve outcomes in ulcerative colitis patients who are in clinical remission but have endoscopic inflammation? Ji Young Chang
(Seoul)
14:18-14:24 Increased risk of end-stage renal disease in metabolically healthy patients with Crohn's disease : A nationwide population-based study Seona Park
(Seoul)
14:24-14:30 Increased risk of parkinson's disease in young patients with Crohn's disease: a nationwide population-based study Seona Park
(Seoul)
14:30-14:36 Increased risk of diabetes in inflammatory bowel disease: A nationwide population-based study in Korea Eun Ae Kang
(Seoul)
14:36-14:42 Increased risk of anxiety and depressive disorders associated with inflammatory bowel disease: a nationwide population-based study Jaeyoung Chun
(Seoul)
14:42-14:48 High-sensitivity C-reactive protein/albumin ratio are associated with disease activity of inflammatory bowel disease Ailing Liu
(Beijing)
14:48-14:54 Characteristics of extra-intestinal manifestations (EIM) in a local cohort of patients with inflammatory bowel disease (IBD) Huiyu Lin
(Singapore)
14:54-15:00 Microbial signature associated with prognosis of Crohns disease Dong Il Park
(Seoul)
15:00-15:06 A comparative study of infusion reactions associated with infliximab, vedolizumab and ustekinumab: Experience from a tertiary hospital in Singapore. Andrew Xia Huang Tan
(Singapore)
15:06-15:12 Low intestinal alkaline phosphatase ratio may predict clinical recurrence in patients with Crohn disease Seon-Young Park
(Gwangju)
15:12-15:18 Development of machine learning model to predict the prognosis in patients with inflammatory bowel disease (IBD) Youni Choi
(Inchoen)
15:18-15:24 Prevalence and associated factors of anemia in Taiwanese inflammatory bowel disease patients Yew Loong Leong
(Taipei)
15:24-15:30 Post-hoc analysis from the Phase 2 FITZROY study with the selective JAK1 inhibitor filgotinib: effect of disease duration and location on clinical remission in Crohns disease patients Wai Keung Leung
(Hong Kong)
E-poster Presentations-07 (LV)
Nov. 16 (Fri)
14:00-15:30
Alcoholic and nonalcoholic liver disease R2A (3F)
Chairperson(s) Manoj Kumar Sharma (New Delhi), Sungjin Hong (Shanghai)
14:00-14:06 Protocatechuic acid-mediated Sirtuin3 activation promotes fatty acid metabolism in non-alcoholic fatty liver disease Jihong Yao
(Dalian)
14:06-14:12 Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis a meta-analysis Higinio Mappala
(Manila)
14:12-14:18 Antioxidants in patients with alcoholic liver disease Le Thi Thu Hien
(Thai Nguyen)
14:18-14:24 Relationship between cytokines and alcoholic liver disease Le Thi Thu Hien
(Thai Nguyen)
14:24-14:30 Severity of non-alcoholic fatty liver disease in Hong Kong and Australia Nicole Phoebe Tanner
(North Point)
14:30-14:36 Alcoholic fatty liver disease among unsafe drinkers: A prospective, community cohort, 7-year follow-up study Madunil Anuk Niriella
(Ragama)
14:36-14:42 Lifestyle Intervention enabled by mobile technologies leading to weight loss in patients with non-alcoholic fatty liver disease: a randomized controlled trial Su Lin Lim
(Singapore)
14:42-14:48 5% weight loss induces NAFLD fibrosis as defined through interval elastography - Preliminary data from a single tertiary hospital in Singapore Wei De Tee
(Singapore)
E-poster Presentations-08 (Surgery)
Nov. 16 (Fri)
14:00-15:30
Surgery: Upper GI, lower GI, others R2C (3F)
Chairperson(s) Kyo Young Song (Seoul), Kent-Man Chu (Hong Kong)
14:00-14:06 Body mass index and mortality in patients with gastric cancer: A large cohort study Jung Hwan Lee
(Incheon)
14:06-14:12 Tranalation and valiadation of eortc qlq-cr29 quality of life questionnaire (sinhala version) Dakshitha Wickramasinghe
(Colombo)
14:12-14:18 Enhanced recovery after colorectal surgery (ERAS) protocol in Sri Lanka an assessment of current practice of colorectal surgery among general surgical units in a developing country in south Asia Chamila Lakmal
(Colombo)
14:18-14:24 Non-exposure simple suturing endoscopic full-thickness resection (NESS-EFTR) with sentinel basin dissection in patients with early gastric cancer Bang Wool Eom
(Goyang)
14:24-14:30 Survival outcomes of local excision versus radical resection for early colorectal cancer in young patients: A propensity matching study Bin Cao
(Beijing)
14:30-14:36 Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis Daisuke Kobayashi
(Nagoya)
14:36-14:42 A single institution experience of laparoscopic gastrectomy in advanced gastric cancer: analysis of postoperative morbidities and long-term oncologic outcomes Sa-Hong Min
(Seongnam)
14:42-14:48 Risk factor and treatments of chylothorax after esophageal cancer surgery Moyuru Yamada
(Toyonakacity)
14:48-14:54 A single center experience of 50 fundoplications in Hong Kong Ho Kiu Grace Wong
(Hong Kong)
Symposium GI-04 (GI Cancer)
Nov. 16 (Fri)
14:00-15:30
Gastirc cancer, are we in new era for management? E1+2 (3F)
Chairperson(s) Hyunyong Jeong (Daejeon), James R. Goldenring (Nashville)
14:00-14:20 The global change in epidemiology of gastric cancer Jin Young Park
(Lyon)
14:20-14:40 Role of?SPEM in gastric carcinogenesis James R. Goldenring
(Nashville)
14:40-15:00 Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery? Keun Won Ryu
(Goyang)
15:00-15:20 Current treatment landscape and future perspectives in patients with advanced gastric cancer Sung Eun Kim
(Busan)
15:20-15:30 Q&As
Free Paper (PB 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (PB 03) E3 (3F)
Chairperson(s) Jaeseon Kim (Seoul), Seon Mee Park (Cheongju)
14:00-14:10 Acalculous cholecystitis in burn intensive care unit patients: Incidence and predisposing factors Hoongoo Lee
(Hwaseong)
14:10-14:20 Clinical characteristics of colonic adenoma according to characteristics of gallstones Jaehyun Tae
(Seoul)
14:20-14:30 Chronological changes of epidemiologic characteristics of gallstone over last 20years in Korean single large volume center Jiyong Zhao
(Seoul)
14:30-14:40 Incidence and risk factors for gallstone formation after surgical and endoscopic therapy Soyeong Kim
(Daegu)
Chairperson(s) Jin Lee (Hwasung), Jong Hyeok Kim (Anyang)
14:40-14:50 Incidence of cholelithiasis in patients with inflammatory bowel disease Sooyeong Kwak
(Daegu)
14:50-15:00 Biliary tuberculosis impersonating as cholangiocarcinoma: Single- center experiences Jae Hyuck Jun
(Daejeon)
15:00-15:10 Outcomes of endoscopic papillary large balloon dilation for bile duct stones: Before and after international consensus guideline Dae Jung Kim
(Suwon)
KDDW Free Paper (LG 3) (Korean)
Nov. 16 (Fri)
14:00-15:30
KDDW Free Paper (LG 3) E5 (3F)
Chairperson(s) Kooklae Lee (Seoul), Soon Man Yoon (Cheongju)
14:00-14:10 Cost drivers for inflammatory bowel disease care: a population-based study using the korean national health insurance claims data (2006-2015) Jung-Wook Kim
(Seoul)
14:10-14:20 Real life effectiveness and safety of vedolizumab as induction therapy for Korean IBD patients in whom anti-TNF treatment failed: A prospective cohort study Jeongseok Kim
(Seoul)
14:20-14:30 Influence of Vitamin D status on the clinical course of ulcerative colitis Nam Seok Ham
(Seoul)
Chairperson(s) Moon Sung Lee (Bucheon), Bo-In Lee (Seoul)
14:30-14:40 Impact of family history of colorectal cancer on age-specific prevalence of colorectal Seulki Kim
(Seoul)
14:40-14:50 The association of cigarette smoking and alcohol consumption with sessile serrated adenoma in 30-49 year-old subjects Ji Young Lee
(Seoul)
14:50-15:00 prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults aged 20 to 39 years Jin Ju Song
(Seoul)
15:00-15:10 Does colon diverticulosis raise the risk of adenomatous colon polyp in patients with colorectal cancer? Suyun Oh
(Suwon)
WEO Honorary Lecture
Nov. 16 (Fri)
16:00-17:00
WEO Honorary Lectureship 104 (1F)
Chairperson(s) Jean-Francois Rey (Saint Laurent Du Var)
16:00-16:50 Paving the way to the globalization of advanced endoscopy Hisao Tajiri
(Tokyo)
16:50-17:00 Q&A
Live Demonstration 2
Nov. 16 (Fri)
16:00-17:30
Live Demonstration 2 Auditorium (3F)
Chairperson(s) Dong Ki Lee (Seoul), Shutian Zhang (Beijing), Mahesh Kumar Goenka (Kolkata)
Judge(s) Laith H. Jamil (Los Angeles), Eun Young Kim (Daegu), Aiming Yang (Beijing), Pradermchai Kongkam (Bangkok), Bo-In Lee (Seoul)
16:00-17:30 UGI, PB Enqiang Linghu
16:00-17:30 UGI Jun Chul Park
Symposium GI-05 (LG)
Nov. 16 (Fri)
16:00-17:30
The cutting edge issues in management of IBD 2018 102 (1F)
Chairperson(s) Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20 What should be the therapeutic targets in IBD therapy? Siew Chien Ng
(Hong Kong)
16:20-16:40 Proper positioning of various drugs in therapeutic algorithm David Todd Rubin
(Chicago)
16:40-17:00 Place of TDM in optimal use of biologics Akira Andoh
(Otsu)
17:00-17:20 Managing Crohn's disease after surgery Kang-Moon Lee
(Suwon)
17:20-17:30 Q&As
Symposium LV-03
Nov. 16 (Fri)
16:00-17:30
Chronic hepatitis C in DAA era 103 (1F)
Chairperson(s) Kwan Soo Byun (Seoul), Rakesh Aggarwal (Lucknow)
16:00-16:20 HCV screening in general population: is this cost-effective in DAA era? Rakesh Aggarwal
(Lucknow)
16:20-16:40 Is there difficult to treat population in HCV patients in DAA era? Naoya Sakamoto
(Sapporo)
16:40-17:00 Increased risk of HCC following DAA: fact or fiction?/Follow up strategy after SVR in chronic hepatitis C Yasuhiro Asahina
(Tokyo)
17:00-17:20 DAA first versus transplantation first in decompensated cirrhotic HCV patients Young-Suk Lim
(Seoul)
17:20-17:30 Q&As
Combined-02 (Endoscopy-Surgery)
Nov. 16 (Fri)
16:00-17:30
Gastrointestinal diseases and treatments in obese patients (KSGE combined session) 105 (1F)
Chairperson(s) Sung Kwan Shin (Seoul), Joo Ho Lee (Seoul)
16:00-16:20 Functional gastrointestinal disorders in obese patients Yong Sung Kim
(Iksan)
16:20-16:40 Gastrointestinal tumors associated with obesity Jin-Hyeok Hwang
(Seongnam)
16:40-17:00 Endoscopic treatments for morbid obesity Hyuk Soon Choi
(Seoul)
17:00-17:20 Surgical treatments for morbid obesity Takeshi Naitoh
(Sendai)
17:20-17:30 Q&As
Symposium GI-06 (UG)
Nov. 16 (Fri)
16:00-17:30
All about GIST on UGI tract 202 (2F)
Chairperson(s) Chang-Hun Yang (Gyeongju), Byung-Wook Kim (Incheon)
16:00-16:20 Pathologic diagnosis; focused on prognostic factor Gu Hyun Kang
(Seoul)
16:20-16:40 Endoscopic treatment: when and how? Hanglak Lee
(Seoul)
16:40-17:00 Surgical treatment: when and how? Hyundong Chae
(Daegu)
17:00-17:20 Target therapy: when and how? Dong-Hoe Koo
(Seoul)
17:20-17:30 Q&As
Symposium PB-03
Nov. 16 (Fri)
16:00-17:30
Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing? 203 (2F)
Chairperson(s) Ho Soon Choi (Seoul), Ji Kon Ryu (Seoul), Dong Sup Yoon (Seoul)
16:00-16:20 Pathogenesis and molecular characterization: from genetics to signaling pathways Young Nyun Park
(Seoul)
16:20-16:40 Pathologic classification: new concepts Kyoungbun Lee
(Seoul)
16:40-17:00 Endoscopic management: from ERCP to EUS Masayuki Kitano
(Wakayama)
17:00-17:20 Selection of patients for curative resection and role of surgery: from resection to transplantation Masayuki Ohtsuka
(Chiba)
17:20-17:30 Dong Hee Koh
(Hwaseong)
APDW 2018 Plenary Oral 2
Nov. 16 (Fri)
16:00-17:30
Plenary Oral 2 205A (2F)
Chairperson(s) Kent-Man Chu (Hong Kong), Ming-Shiang Wu (Taipei)
16:00-16:10 The relationship between enterobacterial flora and prognosis in patient with ulcerative colitis Tomoya Sugiyama
(Nagakute)
16:10-16:20 Analysis of key genes and signaling pathways involved in helicobacter pylori-associated gastric cancer based on the cancer genome atlas database and RNA-sequencing Yi Hu
(Nanchang)
16:20-16:30 Features of post-colonoscopy colorectal cancer and survival times of patients in Korea Jae Myung Cha
(Seoul)
16:30-16:40 An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for helicobacter pylori infection Hiroyuki Tamaki
(Takamatsu)
16:40-16:50 Evolving the novel per oral endoscopic myotomy and fundoplication (POEM+F) procedure: Application of endoscopic hand-suturing technique Akiko Ueno
(Tokyo)
16:50-17:00 POEM is more effective than balloon dilation in all achalasia subtypes: based on data from a single tertiary referral center Ga Hee Kim
(Seoul)
17:00-17:10 Simple liquid arrays of three aptamers are valuable for the diagnosis of gastric cancer Yuting He
(Nanchang)
17:10-17:20 Deep learning versus simple clinical scores for prediction of advanced neoplasia in colorectal cancer screening Hyo-Joon Yang
(Seoul)
17:20-17:30 gut microbiota from patients with colorectal cancer promotes the progression of intestinal adenoma in apcmin/+ mice Hai-Long Cao
(Tianjin)
E-poster Presentations-09 (UG, Motility)
Nov. 16 (Fri)
16:00-17:30
H. pylori, other upper GI disorders R1A (3F)
Chairperson(s) Jae Myung Park (Seoul), Amit Kumar Dutta (Vellore)
16:00-16:06 The study of motor and evacuation functions of the stomach and rectum in patients with functional dyspepsia and irritable bowel syndrome Oybek Otabekovich Usmonov
(Tashkent)
16:06-16:12 Objective and subjective approaches in the treatment of patients with GERD with a syndrome of vegetative dystonia Oybek Otabek O'g'li Usmonov
(Tashkent)
16:12-16:18 Duodenal eosinophil and mast cell count and its relation with functional dyspepsia; A case control study Madhusudan Saha
(Sylhet)
16:18-16:24 Efficacy of endoscopic therapeutic procedures in non variceal upper gastrointestinal bleeding in hanoi medical university hospital from 2013 to 2017 Hang Dao
(Hanoi)
16:24-16:30 The association between electronic cigarette smoking and dyspepsia in adult urban population Ahmad Fariz Malvi Zamzam Zein
(Cirebon)
16:30-15:36 Current risk factors for peptic ulcer disease in the background of declining frequency of helicobacter pylori infection in patients with dyspepsia Amit Kumar Dutta
(Vellore)
16:36-16:42 Impact of upper gastrointestinal symptoms on quality of life in type 2 diabetes patients: preliminary study in Banten province hospital, Indonesia Laras Budiyani
(Serang)
16:42-16:48 Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome Ayesha Shah
(Brisbane)
16:48-16:54 The association between peptic ulcer disease and osteoporosis: A 12-year follow up of the Korean genome and epidemiology study Kanglok Lee
(Incheon)
16:54-17:00 H. pylori genotyping and genomic diversity assessment ingastric biopsies from residents of high altitude ( ladakh ) and lower plains of north India Nisha Sharma
(Delhi)
17:00-17:06 Cost-effectiveness of a tailored helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients Seri Ryu
(Seoul)
E-poster Presentations-10 (LG)
Nov. 16 (Fri)
16:00-17:30
Inflammatory bowel disease (3) R1C (3F)
Chairperson(s) Jae Hee Cheon (Seoul), Vineet Ahuja (New Delhi)
16:00-16:06 The COX-2/PGE2 pathway is central for efficacy of TNF inhibitors and intestinal epithelial regeneration in ulcerative colitis Ole Haagen Nielsen
(Herlev)
16:06-16:12 Using anaemia as an isolated marker to predict the extent of inflammatory bowel disease at diagnosis Hang Hoi Michael Wong
(Hong Kong)
16:12-16:18 Predictors of using traditional medicine, complementary and alternative medicine in inflammatory bowel disease in Hong Kong: the first patients self report in ethnic Chinese Jessica Y L Ching
(Hong Kong)
16:18-16:24 Age at onset, maintenance therapy and erythrocyte sedimentation rate are independent risk factors for anal fistula in Crohns disease Guanghui Lian
(Changsha)
16:24-16:30 Disease activity and severity of ulcerative colitis are associated with increased mucosal candida colonization and Beta-D-Glucan levels Jimil Hiteshbhai Shah
(Chandigarh)
16:30-15:36 Incidence and outcomes of acute severe ulcerative colitis (ASUC) - A retrospective cohort study in a Singapore tertiary institution Kaina Chen
(Singapore)
16:36-16:42 Molecular detection of pathogenic gut bacteria in inflammatory bowel disease (IBD) patients is not influenced by disease activity Deborah Chia Hsin Chew
(Malaysia)
16:42-16:48 Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004-2015 Jae Jun Park
(Seoul)
16:48-16:54 Study of predictive factors and clinical implication of deep mucosal healing in ulcerative colitis Deepak Gupta
(Mumbai)
16:54-17:00 Natural history of inflammatory bowel disease from 1970 to 2017 - Results from a large single center in Singapore Miao Shan Lim
(Singapore)
E-poster Presentations-11 (LV)
Nov. 16 (Fri)
16:00-17:30
Autoimmune liver disease, cirrhosis R2A (3F)
Chairperson(s) Il Han Song (Cheonan), Kang Mo Kim (Seoul)
16:00-16:06 Fluorofenidone reveals a novel function for glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and hepatic fibrosis Yu Peng
(Changsha)
16:06-16:12 Rapid endoscopic ultrasound screening of hepatopulmonary syndrome (RUSH): a safe, simple and quick procedure for gastroenterologist Rahul Pundlik Talele
(Meerut)
16:12-16:18 Outcomes of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis. Rabeea Azmat
(Karachi)
16:18-16:24 PXR activation by ginkgolide a restores inflammation and tight junction integrity in cirrhosis Balasubramaniyan Vairappan
(Pondicherry)
16:24-16:30 Tofacitinib ameliorates inflammation effectively in immune-mediated hepatic injury Han Wang
(Wuhan)
16:30-15:36 The demographic, clinical features, response to treatment and outcome of autoimmune hepatitis (AIH) patients in multi-ethnic Malaysia since 2002 Yun Chien Chung
(Batu Caves)
16:36-16:42 The distribution of non-tumoral portal vein thrombosis in liver cirrhosis and its relationship with wall shear stress Zongfang Li
(Xi'an)
16:42-16:48 A gravity-assisted liver stiffness measurement Itsuo Nagayama
(Minami Uonuma)
16:48-16:54 Repeated versus single treatment of esophageal variceal ligation after esophageal variceal bleeding: Multicenter retrospective study Young Hwan Choi
(Seoul)
16:54-17:00 Gastric vascular ectasia (GAVE) not rare cause of GI bleed in liver cirrhosis ; cross sectional study on factors associated with GAVE with or with out portal hypertensive gastropathy (PHG) in liver cirrhosis in tertiary care hospital Karachi Paksitan Om Parkash
(Karachi)
E-poster Presentations-12 (PB)
Nov. 16 (Fri)
16:00-17:30
Endoscopic retrograde cholangiopancreatography (ERCP) R2C (3F)
Chairperson(s) Sang-Woo Cha (Seoul), Ari Fahrial Syam (Depok)
16:00-16:06 Demonstrating competence in endoscopic retrograde cholangiopancreaticography (ERCP): recently credentialed operators performance for deep biliary cannulation over 1 year period from tertiary care hospital in Pakistan. Om Parkash
(Karachi)
16:06-16:12 A retrospective comparison of transpancreatic septotomy and needle knife sphincterotomy in difficult biliary cannulation Cherng Harng Lim
(Chanhua)
16:12-16:18 The usefulness of newly modified non-flared fully covered metal stent of 12 mm-diameter comparing with conventional stent for periampullary malignant biliary strictures Jin Yong Lee
(Bucheon)
16:18-16:24 Bile duct injury after laparoscopic cholecystectomy: new classification and novel approach for the management in emergency situations. Chintan Patel
(Surat)
16:24-16:30 Patterns of bile duct injuries observed during endoscopic retrograde cholangiogram: 13 years of experience in a tertiary care referral centre in south Asia Chamila Lakmal
(Colombo)
16:30-15:36 Endoscopic management of difficult biliary stones; utility of ERCP using short type double balloon endoscope in patients with surgically altered anatomy Masaaki Shimatani
(Osaka)
16:36-16:42 The sphincter-preserving effect of duodenal papilla occlusion by SureClip from MicroTech Yonghui Huang
(Beijing)
16:42-16:48 Clinical utility of endoscopic therapy for bile leak associated with posthepatobiliary surgery Hideyuki Shiomi
(Kobe)
16:48-16:54 A novel technique using loop-device for the repositioning of ENBD catheter in ERCP Jae Min Lee
(Seoul)
16:54-17:00 Efficacy of endoscopic plastic stents for anastomotic biliary strictures after right lobe adult living donor liver transplantation Min Su You
(Seoul)
17:00-17:06 Proper initial stent type for palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction Young Hoon Choi
(Seoul)
17:06-17:12 Risk of failure and complications of endoscopic retrograde cholangiopancreatography; comparison of elderly and young pakistani patients Talal Khurshid
(Islamabad)
PG Course-LG (Korean)
Nov. 16 (Fri)
16:00-17:30
Current status and future perspectives in management of small bowel diseases E1+2 (3F)
Chairperson(s) Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20 Optimal approach to small bowel bleeding Hyun Jung Lee
(Seoul)
16:20-16:40 Radiologic diagnosis of small bowel diseases Jeong Kyong Lee
(Seoul)
16:40-17:00 Therapeutic role of enteroscopy Sung Noh Hong
(Seoul)
17:00-17:20 Interesting cases of various small bowel diseases Bong Min Ko
(Bucheon)
17:20-17:30 Q&As
Free Paper (PB 4) (Korean)
Nov. 16 (Fri)
16:00-17:30
KDDW Free Paper (PB 04) E3 (3F)
Chairperson(s) Seong Woo Nam (Seoul), Young Koog Cheon (Seoul)
16:00-16:10 Antitumor effects of flavokawain B on cholangiocarcinoma Young Hoon Choi
(Seoul)
16:10-16:20 Carbohydrate antigen 19-9 as a prognostic marker of intrahepatic cholangiocarcinoma after surgical resection Gunn Huh
(Seoul)
16:20-16:30 Clinical relevance of BilIN in surgical margin of perihilar cholangiocarcinoma Soong Goo Jung
(Seoul)
Chairperson(s) Young Soo Moon (Busan), Se-Joon Lee (Yongin)
16:30-16:40 Efficacy and safety of simultaneous side-by-side bilateral placement of braided-type metal stents using 6F-introducer for unresectable malignant hilar bile duct obstruction: A retrospective feasibility study Doo Hyun Ko
(Inchon)
16:40-16:50 Comparison of preoperative CT scan, EUS Findings, and Histopathologic Findings of Gallbladder Polyps Larger than 1 cm in Size Jae Kook Yang
(Cheonan)
16:50-17:00 Long-term outcomes of endoscopic papillectomy after an insulated plastic pancreatic stent placement Sun Ung Youn
(Suwon)
AGA-APAGE
Nov. 16 (Fri)
16:00-18:00
From bench to clinic in gastric cancer: Where are we headed? 101 (1F)
Chairperson(s) Emad Munir El-Omar (Sydney), Sang Woo Lee (Ansan)
16:00-16:25 The molecular pathogenesis of gastric cancer ? state of the art Timothy Cragin Wang
(New York)
16:25-16:50 The role of the gastric microbiome in H. pylori-induced gastric cancer Richard Peek
(Nashville)
16:50-17:15 Prevention of gastric cancer ? opportunities and potential problems Kentaro Sugano
(Shimotsuke)
17:15-17:40 National gastric cancer screening- outcomes and future challenges Il Ju Choi
(Goyang)
17:40-18:00 Q&As